We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YSS:NYSEYork Space Systems Inc. Analysis

Data as of 2026-08-31 - not real-time

$8.97

Latest Price

9/10Risk

Risk Level: High

Executive Summary

York Space Systems, Inc. trades at $8.97, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has lost 50.0%. Momentum indicators put RSI at 28.3 (oversold) with MACD reading bullish. Recent trading has carved out support near $8.89 and resistance around $16.00.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 107.9% above the current quote. Revenue is growing at 10.4% on a -50.1% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 105.7%, a beta of 2.51 and a maximum drawdown of 79.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.

Top Market Events

Securities Fraud Investigation Into York Space Systems, Inc.Securities Fraud Investigation Into York Space Systems, Inc.York Space Systems announced that Chief Financial Officer Kevin Messerle will leave the company after filing its...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 28.3 signals oversold conditions
  • Trading below the 200-day average of 24.53

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 28.3 signals oversold conditions
  • Trading below the 200-day average of 24.53

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -50.1%
  • Analyst targets imply +107.9% versus the current price
  • Revenue growth of +10.4%

Key Metrics & Analysis

Financial Health

Revenue Growth10.40%
Profit Margin-50.06%
P/E Ratio-76.9
Debt/Equity10.16
P/B Ratio0.7
Op. Cash Flow$-208144992
Industry P/E29.4

Technical Analysis

TrendBearish
RSI28.3
Support$8.89
Resistance$16.00
MA 20$10.79
MA 50$17.02
MA 200$24.53
MACDBullish
VolumeDecreasing
Fear & Greed Index94.11

Valuation

Target Price$18.65
Upside/Downside107.92%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.51
Volatility105.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.